MyChesCo on MSN
New clue to colon cancer’s origins points to slowed cell renewal, not runaway growth
WILMINGTON, DE — Colorectal cancer, long thought to begin when cells start growing out of control, may instead take root when ...
Seismic Therapeutic Inc. has provided preclinical data for S-4321, a novel dual-cell bidirectional (DcB) PD-1:FcγRIIb antibody being developed for the treatment of autoimmune disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results